Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Advances in Therapy|June 18, 2016
Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)Laura S Gold, Kangho Suh, Patricia B Schepman, et al.Journal of Managed Care & Specialty Pharmacy|June 2, 2024
Projecting long-term clinical outcomes with larotrectinib compared with immune checkpoint inhibitors in metastatic nonsmall cell lung cancer and differentiated thyroid cancerKangho Suh, Ashley Kang, Gilbert Ko, et al.Journal of Managed Care & Specialty Pharmacy|September 26, 2017
Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription DrugsKai Yeung, Kangho Suh, Anirban Basu, et al.Pharmacotherapy|January 14, 2026
Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell DiseaseSiang-Hao Cheng, Enrico M Novelli, Hyeun Ah Kang, et al.Research in Social & Administrative Pharmacy : RSAP|August 14, 2025
Public, private, and out-of-pocket spending comparisons between respondents with and without opioids and the impact of the Comprehensive Addiction Recovery Act, 2008-2020: A serial cross-sectional studyMark Bounthavong, Meng Li, Aryana Sepassi, et al.International Journal for Equity in Health|February 25, 2025
Association of federal poverty level with healthcare expenditures among opioids users in the United States (2008-2019): a serial cross-sectional studyMark Bounthavong, Kangho Suh, Aryana Sepassi, et al.Substance Abuse Treatment, Prevention, and Policy|October 21, 2021
Trends in healthcare expenditures and resource utilization among a nationally representative population with opioids in the United States: a serial cross-sectional study, 2008 to 2017Mark Bounthavong, Kangho Suh, Meng Li, et al.Research in Social & Administrative Pharmacy : RSAP|November 11, 2019
Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessmentMark Bounthavong, Kangho Suh, Melissa L D Christopher, et al.Neurology and Therapy|May 22, 2022
Patterns of Utilization and Expenditure Across Multiple Sclerosis Disease-Modifying Therapies: A Retrospective Cohort Study Using Claims Data from a Commercially Insured Population in the United States, 2010-2019Wen Zhu, Xiaoyu Tang, Rock A Heyman, et al.Chest|February 13, 2015
Economic Burden of COPD in the Presence of ComorbiditiesDavid M Mannino, Keiko Higuchi, Tzy-Chyi Yu, et al.Pageof 5